Stryker Corporation (LON:0R2S)
373.69
-25.80 (-6.46%)
At close: Aug 1, 2025
Altus Power Revenue
Stryker had revenue of $6.02B USD in the quarter ending June 30, 2025, with 11.07% growth. This brings the company's revenue in the last twelve months to $23.82B, up 11.36% year-over-year. In the year 2024, Stryker had annual revenue of $22.60B with 10.23% growth.
Revenue (ttm)
$23.82B
Revenue Growth
+11.36%
P/S Ratio
6.27
Revenue / Employee
$449.40K
Employees
53,000
Market Cap
109.00B
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 22.60B | 2.10B | 10.23% |
Dec 31, 2023 | 20.50B | 2.05B | 11.11% |
Dec 31, 2022 | 18.45B | 1.34B | 7.84% |
Dec 31, 2021 | 17.11B | 2.76B | 19.21% |
Dec 31, 2020 | 14.35B | -533.00M | -3.58% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |
Stryker News
- 1 day ago - 10 stocks favored to gain up to 30% in a sector that has missed this year's rally - Market Watch
- 4 days ago - Inari Medical, now part of Stryker, launches the all-new InThrill® Thrombectomy System, designed to address arteriovenous access and small vessel thrombus cases - PRNewsWire
- 15 days ago - Rep. Thomas Kean Has Sold Up to $65K Worth Of Stryker Stock: Here's What You Should Know - Benzinga
- 21 days ago - Looking Into Stryker's Recent Short Interest - Benzinga
- 22 days ago - North America Cystoscopes Market Outlook Report 2025-2033 Featuring Key Companies - Olympus, KARL STORZ, Stryker, PENTAX Medical, Richard Wolf, Ambu, Laborie Medical Technologies - GlobeNewsWire
- 22 days ago - Cathie Wood Vs. Jim Cramer: TV Host Says Top Ark AI Pick 'Losing Money Hand Over Fist' - Benzinga
- 4 weeks ago - Here's How Much You Would Have Made Owning Stryker Stock In The Last 5 Years - Benzinga
- 4 weeks ago - Stryker to announce financial results for its second quarter of fiscal year 2025 - GlobeNewsWire